{"id":"autologous-mscs","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Infection at harvest or injection site"},{"rate":null,"effect":"Immune reaction"}]},"_chembl":{"chemblId":"CHEMBL5315092","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"MSCs are multipotent cells capable of differentiating into various cell types (osteocytes, chondrocytes, adipocytes) and secreting immunomodulatory factors that reduce inflammation and promote tissue regeneration. When administered autologously, they can home to damaged tissues and facilitate repair through both direct differentiation and paracrine effects. This approach leverages the patient's own cells to minimize rejection risk while harnessing regenerative and anti-inflammatory properties.","oneSentence":"Autologous mesenchymal stem cells (MSCs) are harvested from the patient's own bone marrow or adipose tissue and administered to promote tissue repair and modulate immune responses.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:58.651Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cartilage defects and osteoarthritis (likely primary indication based on MSC development history)"}]},"trialDetails":[{"nctId":"NCT06798623","phase":"PHASE1","title":"Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-24","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":15},{"nctId":"NCT04749667","phase":"PHASE1, PHASE2","title":"Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2021-08-09","conditions":"Multiple Sclerosis, Progressive Multiple Sclerosis","enrollment":18},{"nctId":"NCT07465198","phase":"PHASE2","title":"Autologous Stem Cell Therapy in Patients With Multiple System Atrophy","status":"NOT_YET_RECRUITING","sponsor":"Biocells Medical","startDate":"2026-09-01","conditions":"MSA - Multiple System Atrophy, MSA","enrollment":50},{"nctId":"NCT07238062","phase":"","title":"\"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy.\"","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Multiple System Atrophy","enrollment":""},{"nctId":"NCT03268603","phase":"PHASE2","title":"Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-10-10","conditions":"ALS, Amyotrophic Lateral Sclerosis","enrollment":75},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT05095532","phase":"PHASE1","title":"Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2021-12-01","conditions":"Chronic Pancreatitis, Mesenchymal Stem Cells","enrollment":42},{"nctId":"NCT06726538","phase":"PHASE1, PHASE2","title":"Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2023-10-01","conditions":"Female Sexual Dysfunction","enrollment":50},{"nctId":"NCT04312113","phase":"PHASE1","title":"Angiographic Delivery of AD-MSC for Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-11-16","conditions":"Ulcerative Colitis","enrollment":20},{"nctId":"NCT04650568","phase":"NA","title":"Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction","status":"ENROLLING_BY_INVITATION","sponsor":"Rush University Medical Center","startDate":"2017-11-03","conditions":"Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture","enrollment":100},{"nctId":"NCT05080465","phase":"PHASE3","title":"Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis","status":"COMPLETED","sponsor":"Ukraine Association of Biobank","startDate":"2018-12-02","conditions":"Liver Cirrhosis","enrollment":700},{"nctId":"NCT03608579","phase":"PHASE1","title":"Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-11-05","conditions":"Osteoarthritis, Hip","enrollment":24},{"nctId":"NCT03477942","phase":"PHASE1","title":"Impact of Mesenchymal Stem Cells in Knee Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2018-10-01","conditions":"Musculoskeletal Pain, Knee Osteoarthritis, Cartilage Injury","enrollment":16},{"nctId":"NCT04907188","phase":"","title":"Individual Patient Expanded Access IND for the Treatment of Stroke","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Stroke, Stroke, Ischemic","enrollment":""},{"nctId":"NCT04064957","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord Injury","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Spinal Cord Injuries","enrollment":""},{"nctId":"NCT04029896","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Cerebral Palsy","enrollment":""},{"nctId":"NCT04825626","phase":"","title":"An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Chronic Inflammatory Demyelinating Polyneuropathy","enrollment":""},{"nctId":"NCT04604288","phase":"","title":"Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Knee Pain Chronic, Osteo Arthritis Knee","enrollment":""},{"nctId":"NCT04772378","phase":"","title":"Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Parkinson Disease","enrollment":""},{"nctId":"NCT04514952","phase":"","title":"Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Amyotrophic Lateral Sclerosis","enrollment":""},{"nctId":"NCT03925649","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences LLC","startDate":"","conditions":"Spinal Cord Injury at C5-C7 Level","enrollment":""},{"nctId":"NCT04798066","phase":"","title":"Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Post COVID-19 Syndrome","enrollment":""},{"nctId":"NCT04711811","phase":"","title":"Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Chronic Pain","enrollment":""},{"nctId":"NCT05116540","phase":"PHASE2","title":"Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-11-24","conditions":"Multiple Sclerosis","enrollment":24},{"nctId":"NCT03691909","phase":"PHASE1, PHASE2","title":"Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Hope Biosciences LLC","startDate":"2018-09-25","conditions":"Rheumatoid Arthritis","enrollment":15},{"nctId":"NCT07157891","phase":"EARLY_PHASE1","title":"Investigating the Safety and Regenerative Potential of MSC-Derived Secretome Combined With PRGF in Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"University of the Punjab","startDate":"2025-12-10","conditions":"Osteoarthritis (OA), Knee Injury, Cartilage Degeneration","enrollment":25},{"nctId":"NCT04042844","phase":"PHASE2","title":"A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)","status":"RECRUITING","sponsor":"BioRestorative Therapies","startDate":"2022-06-30","conditions":"Lumbar Disc Disease","enrollment":99},{"nctId":"NCT06789302","phase":"PHASE2","title":"A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Global Institute of Stem Cell Therapy and Research","startDate":"2025-12","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":120},{"nctId":"NCT05925036","phase":"PHASE1","title":"Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-01-01","conditions":"Chronic Pancreatitis, Chronic Pain","enrollment":40},{"nctId":"NCT06205342","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-07-17","conditions":"Chronic Pancreatitis, Chronic Pain","enrollment":48},{"nctId":"NCT04297813","phase":"PHASE3","title":"Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting","status":"COMPLETED","sponsor":"University of Bergen","startDate":"2020-03-12","conditions":"Alveolar Bone Atrophy","enrollment":48},{"nctId":"NCT03355365","phase":"PHASE2","title":"Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Tisch Multiple Sclerosis Research Center of New York","startDate":"2018-09-21","conditions":"Multiple Sclerosis","enrollment":54},{"nctId":"NCT07010926","phase":"PHASE2","title":"A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease","status":"NOT_YET_RECRUITING","sponsor":"L2 Bio, LLC","startDate":"2025-08-15","conditions":"Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)","enrollment":120},{"nctId":"NCT07011199","phase":"PHASE1","title":"Clinical Outcomes of Early Kasai Surgery With Umbilical Cord MSCs in Biliary Atresia","status":"NOT_YET_RECRUITING","sponsor":"Universitas Diponegoro","startDate":"2025-06-17","conditions":"Biliary Atresia, Kasai Portoenterostomy, Mesenchymal Stem Cell Transplantation","enrollment":14},{"nctId":"NCT06951074","phase":"PHASE2, PHASE3","title":"Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Stem Cells, Type 1 Diabetes","enrollment":20},{"nctId":"NCT04489732","phase":"PHASE1","title":"MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2022-02-18","conditions":"Xerostomia Following Radiotherapy","enrollment":6},{"nctId":"NCT02315027","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy in Multiple System Atrophy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2012-10","conditions":"MSA","enrollment":30},{"nctId":"NCT04435249","phase":"PHASE1, PHASE2","title":"ENgineered Tissue Repair of BronchopleUral FiSTula","status":"WITHDRAWN","sponsor":"Videregen Limited","startDate":"2025-10","conditions":"Bronchopleural Fistula","enrollment":""},{"nctId":"NCT05947175","phase":"NA","title":"Vertebral Bone Marrow Clot for Spinal Surgery","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2023-05-19","conditions":"Degenerative Spine Diseases","enrollment":96},{"nctId":"NCT03478215","phase":"PHASE2","title":"Mesenchymal Stromal Cells in Living Donor Kidney Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2016-12","conditions":"Renal Transplantation, Mesenchymal Stem Cells","enrollment":24},{"nctId":"NCT06858254","phase":"PHASE1, PHASE2","title":"Standard Optimization of Stem Cells in Parkinson's Disease and Atypical Parkinsonism","status":"NOT_YET_RECRUITING","sponsor":"Apeiron Research Center","startDate":"2025-04-01","conditions":"Atypical Parkinsonism, Parkinson Disease (PD)","enrollment":60},{"nctId":"NCT03379168","phase":"NA","title":"Efficacy of Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis.","status":"COMPLETED","sponsor":"Dustin L. Richter, MD","startDate":"2018-04-01","conditions":"Knee Osteoarthritis","enrollment":75},{"nctId":"NCT01842477","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2013-05","conditions":"Delayed Union After Fracture of Humerus, Tibial or Femur","enrollment":30},{"nctId":"NCT04815213","phase":"PHASE1","title":"The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Jordan","startDate":"2022-01-01","conditions":"Premature Ovarian Failure","enrollment":10},{"nctId":"NCT06326203","phase":"PHASE1, PHASE2","title":"Cell Therapy for Lower Limb Ulcers in Patients With Critical Limb Ischemia","status":"NOT_YET_RECRUITING","sponsor":"UPECLIN HC FM Botucatu Unesp","startDate":"2025-05-01","conditions":"Peripheral Arterial Disease, Leg Ulcer","enrollment":40},{"nctId":"NCT03325504","phase":"PHASE3","title":"A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union","status":"COMPLETED","sponsor":"Universidad Autonoma de Madrid","startDate":"2017-09-05","conditions":"Non Union Fracture","enrollment":46},{"nctId":"NCT05086939","phase":"PHASE3","title":"Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León","startDate":"2021-05-26","conditions":"Knee Osteoarthritis","enrollment":124},{"nctId":"NCT03346967","phase":"PHASE1, PHASE2","title":"Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2017-11-01","conditions":"Hormone Deficiency","enrollment":30},{"nctId":"NCT05329662","phase":"PHASE2","title":"Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female","status":"RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2023-05-01","conditions":"Sexual Dysfunction Female","enrollment":130},{"nctId":"NCT06400862","phase":"PHASE1","title":"Treating Patients With Traumatic Chondral Lesions With Autologous Bone Marrow Cells Derived Engineered Tissues - Engineered Osteochondral Tissue","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-02-26","conditions":"Traumatic Cartilage Injury","enrollment":9},{"nctId":"NCT05081921","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2022-01-05","conditions":"Osteoarthritis of Knee","enrollment":192},{"nctId":"NCT06028763","phase":"NA","title":"Development of Biomedical Technology for the Treatment of Ankle Cartilage Using Injectable Biocomposite Hydrogel","status":"UNKNOWN","sponsor":"National Scientific Center of Traumatology and Orthopedics named after academician N.D. Batpenov","startDate":"2023-07-01","conditions":"Ankle Osteoarthritis","enrollment":40},{"nctId":"NCT02696876","phase":"NA","title":"Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair","status":"COMPLETED","sponsor":"University of Leeds","startDate":"2017-01","conditions":"Defect of Articular Cartilage, Cartilage Injury, Osteoarthritis, Knee","enrollment":4},{"nctId":"NCT06103396","phase":"PHASE1, PHASE2","title":"Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs)","status":"UNKNOWN","sponsor":"Instituto Venezolano de Investigaciones Cientificas","startDate":"2018-01-30","conditions":"Pseudoarthrosis of Bone, Pseudarthrosis, Non Union Fracture","enrollment":30},{"nctId":"NCT06103409","phase":"PHASE1, PHASE2","title":"MSCs for the Treatment of Burn Wounds","status":"UNKNOWN","sponsor":"Instituto Venezolano de Investigaciones Cientificas","startDate":"2021-06-30","conditions":"Burn Wound, Second- or Third-degree Burn","enrollment":50},{"nctId":"NCT05936047","phase":"NA","title":"Bone Marrow Clot for Posterior Lumbar Fusion","status":"COMPLETED","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2020-11-27","conditions":"Spinal Fusion","enrollment":10},{"nctId":"NCT05827757","phase":"PHASE1, PHASE2","title":"Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Anti-inflammatory Cytokines on Ageing-related Low-grade Inflammation Patients.","status":"UNKNOWN","sponsor":"DNA International Hospital","startDate":"2020-04-28","conditions":"Aging Problems, Aging, Chronic Inflammation","enrollment":72},{"nctId":"NCT05975892","phase":"PHASE1, PHASE2","title":"Transplantation of Bone Marrow Mesenchymal Stromal Cells for Periodontal Regeneration","status":"UNKNOWN","sponsor":"Instituto Venezolano de Investigaciones Cientificas","startDate":"2018-08-30","conditions":"Chronic Periodontal Disease, Aggressive Periodontitis","enrollment":30},{"nctId":"NCT03818737","phase":"PHASE3","title":"Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-03-28","conditions":"Osteoarthritis","enrollment":475},{"nctId":"NCT04427930","phase":"PHASE3","title":"Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"R-Bio","startDate":"2020-04-13","conditions":"Knee Osteoarthritis","enrollment":129},{"nctId":"NCT01730547","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells for Multiple Sclerosis","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2013-02","conditions":"Multiple Sclerosis","enrollment":2},{"nctId":"NCT02012153","phase":"PHASE1","title":"Mesenchymal Stromal Cells in Kidney Transplant Recipients","status":"TERMINATED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2013-12-04","conditions":"Kidney Transplant Rejection","enrollment":3},{"nctId":"NCT02462330","phase":"PHASE2","title":"Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2016-02-19","conditions":"Chronic Myocardial Ischemia","enrollment":39},{"nctId":"NCT05783154","phase":"PHASE2, PHASE3","title":"Effect of Mesenchymal Stem Cells in Primary Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2022-09-16","conditions":"Osteoarthritis Knee","enrollment":84},{"nctId":"NCT02025270","phase":"PHASE1, PHASE2","title":"MSCs For Treatment of Azoospermic Patients","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2012-10-15","conditions":"Male Infertility","enrollment":100},{"nctId":"NCT02359929","phase":"PHASE1","title":"BMT Autologous MSCs for GvHD","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-01","conditions":"Graft Versus Host Disease, Acute Graft Versus Host Disease, Chronic Graft Versus Host Disease","enrollment":11},{"nctId":"NCT05671796","phase":"PHASE2","title":"Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury","status":"UNKNOWN","sponsor":"SENAI CIMATEC","startDate":"2023-04-01","conditions":"Spinal Cord Injuries","enrollment":40},{"nctId":"NCT01719640","phase":"PHASE1, PHASE2","title":"MSC and MC in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Fuzhou General Hospital","startDate":"2011-01","conditions":"Diabetes Mellitus, Type 2","enrollment":22},{"nctId":"NCT05631444","phase":"PHASE1, PHASE2","title":"Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia","status":"COMPLETED","sponsor":"Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle","startDate":"2019-01-01","conditions":"Chronic Limb-threatening Ischemia, Diabetes Mellitus","enrollment":24},{"nctId":"NCT03990805","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis","status":"COMPLETED","sponsor":"R-Bio","startDate":"2019-06-11","conditions":"Degenerative Arthritis, Knee Osteoarthritis","enrollment":260},{"nctId":"NCT04821102","phase":"NA","title":"Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration","status":"UNKNOWN","sponsor":"R-Bio","startDate":"2023-07-01","conditions":"Degenerative Arthritis, Knee Arthritis","enrollment":21},{"nctId":"NCT02449005","phase":"PHASE1, PHASE2","title":"Autologous Alveolar Bone Marrow Mesenchymal Stem Cells for the Reconstruction of Infrabony Periodontal Defects","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2014-03","conditions":"Chronic Periodontitis","enrollment":30},{"nctId":"NCT02497443","phase":"PHASE1, PHASE2","title":"Safety of Autologous MSC Infusion to Treat Epilepsy","status":"COMPLETED","sponsor":"Ministry of Public Health, Republic of Belarus","startDate":"2011-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT02384018","phase":"PHASE1","title":"Mesenchymal Stem Cell and Islet Co-transplantation","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2014-12","conditions":"Chronic Pancreatitis, Diabetes","enrollment":3},{"nctId":"NCT05288725","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy for Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Next Generation Regenerative Medicine LLC","startDate":"2022-08","conditions":"Osteoarthritis, Knee","enrollment":120},{"nctId":"NCT03461458","phase":"PHASE1","title":"Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc Disease","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2018-10-17","conditions":"Degenerative Disc Disease","enrollment":1},{"nctId":"NCT02065167","phase":"PHASE2","title":"Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip","status":"COMPLETED","sponsor":"Universidad Autonoma de Madrid","startDate":"2014-02","conditions":"Avascular Necrosis of the Femoral Head","enrollment":26},{"nctId":"NCT02501811","phase":"PHASE2","title":"Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2015-10","conditions":"Ischemic Cardiomyopathy","enrollment":125},{"nctId":"NCT04823000","phase":"PHASE1, PHASE2","title":"Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Hadassah Medical Organization","startDate":"2013-01-01","conditions":"Multiple Sclerosis","enrollment":24},{"nctId":"NCT04821479","phase":"PHASE1, PHASE2","title":"Repeated Mesenchymal Stem Cell Injections in ALS","status":"COMPLETED","sponsor":"Hadassah Medical Organization","startDate":"2016-01-01","conditions":"Amyotrophic Lateral Sclerosis","enrollment":20},{"nctId":"NCT03626090","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy for Liver Cirrhosis","status":"UNKNOWN","sponsor":"Stem Med Pte. Ltd.","startDate":"2018-08-18","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT03000712","phase":"NA","title":"Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.","status":"COMPLETED","sponsor":"R-Bio","startDate":"2016-11-02","conditions":"Degenerative Arthritis, Knee Osteoarthritis","enrollment":26},{"nctId":"NCT04675359","phase":"PHASE4","title":"Adipose-derived MSCs After Enzymatic Digestion vs. Mechanically Fragmented Fat Transfer in Knee Osteoarthritis Treatment","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2021-07-01","conditions":"Knee Osteoarthritis, Chondropathy","enrollment":100},{"nctId":"NCT03838250","phase":"PHASE1","title":"Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC","status":"UNKNOWN","sponsor":"Pharmicell Co., Ltd.","startDate":"2019-06-20","conditions":"Alcoholic Liver Cirrhosis","enrollment":10},{"nctId":"NCT03933995","phase":"","title":"Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction","status":"UNKNOWN","sponsor":"Pharmicell Co., Ltd.","startDate":"2019-03-11","conditions":"Erectile Dysfunction","enrollment":10},{"nctId":"NCT02566655","phase":"PHASE1","title":"Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis","status":"COMPLETED","sponsor":"Red de Terapia Celular","startDate":"2015-09","conditions":"Osteoporosis, Spinal Fractures","enrollment":10},{"nctId":"NCT02057965","phase":"PHASE2","title":"Mesenchymal Stromal Cell Therapy in Renal Recipients","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2014-03","conditions":"Renal Transplant Rejection, Fibrosis","enrollment":70},{"nctId":"NCT04545307","phase":"PHASE2, PHASE3","title":"Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis","status":"COMPLETED","sponsor":"Universidad Central de Venezuela","startDate":"2019-11-27","conditions":"Pulp Necroses, Apical Periodontitis","enrollment":5},{"nctId":"NCT02323477","phase":"PHASE1, PHASE2","title":"Human Umbilical Cord Stroma MSC in Myocardial Infarction","status":"TERMINATED","sponsor":"Ankara University","startDate":"2015-02-02","conditions":"Chronic Ischemic Cardiomyopathy, Coronary Artery Bypass Surgery","enrollment":46},{"nctId":"NCT04326985","phase":"EARLY_PHASE1","title":"RCT Mesenchymal Stem Cells Versus Hyaluronic Acid in OA Knee):","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2015-01-31","conditions":"Osteoarthritis, Knee","enrollment":20},{"nctId":"NCT02239393","phase":"PHASE2","title":"Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2015-06","conditions":"Multiple Sclerosis","enrollment":31},{"nctId":"NCT01552707","phase":"PHASE1, PHASE2","title":"Safety Study of Mesenchymal Stem Cells and Spinal Fusion","status":"COMPLETED","sponsor":"Banc de Sang i Teixits","startDate":"2012-07-19","conditions":"Lumbar Spondylolisthesis Involving L4-L5, and/or, Degenerative Discopathy Involving L4-L5","enrollment":69},{"nctId":"NCT04210440","phase":"NA","title":"The Treatment of Initial Stage of Hip Osteonecrosis: the Core Decompression","status":"COMPLETED","sponsor":"Dante Dallari, MD","startDate":"2003-03-01","conditions":"Hip Necrosis, Hip Injuries","enrollment":52},{"nctId":"NCT04174898","phase":"PHASE1","title":"MSC Infusion for Anti-aging and Regenerative Therapy","status":"UNKNOWN","sponsor":"Landmark Medical Centre Sdn Bhd","startDate":"2020-04-15","conditions":"Aging Well, Regenerative Medicine","enrollment":100},{"nctId":"NCT02351011","phase":"PHASE1, PHASE2","title":"Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA","status":"COMPLETED","sponsor":"Jas Chahal","startDate":"2015-02","conditions":"Osteoarthritis of Knee","enrollment":12},{"nctId":"NCT00587990","phase":"PHASE1, PHASE2","title":"Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)","status":"TERMINATED","sponsor":"Joshua M Hare","startDate":"2007-11","conditions":"Stem Cell Transplantation, Ventricular Dysfunction, Left","enrollment":9},{"nctId":"NCT04078308","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients","status":"UNKNOWN","sponsor":"Royan Institute","startDate":"2015-07-06","conditions":"Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Insulin-Dependent","enrollment":20},{"nctId":"NCT02166021","phase":"PHASE2","title":"Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Dimitrios Karussis","startDate":"2015-01-29","conditions":"Multiple Sclerosis (MS)","enrollment":48},{"nctId":"NCT01309061","phase":"NA","title":"The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease","status":"COMPLETED","sponsor":"R-Bio","startDate":"2008-03","conditions":"Progressive Hemifacial Atrophy, Romberg's Disease","enrollment":5},{"nctId":"NCT01663376","phase":"NA","title":"Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia","status":"COMPLETED","sponsor":"R-Bio","startDate":"2009-01","conditions":"Critical Limb Ischemia","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Autologous MSCs","genericName":"Autologous MSCs","companyName":"Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León","companyId":"fundaci-n-instituto-de-estudios-de-ciencias-de-la-salud-de-castilla-y-le-n","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Autologous mesenchymal stem cells (MSCs) are harvested from the patient's own bone marrow or adipose tissue and administered to promote tissue repair and modulate immune responses. Used for Cartilage defects and osteoarthritis (likely primary indication based on MSC development history).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}